RS52481B - FORMULATION OF HFA-SUSPENSION CONTAINING ANHYDRATE - Google Patents

FORMULATION OF HFA-SUSPENSION CONTAINING ANHYDRATE

Info

Publication number
RS52481B
RS52481B YU86004A YUP86004A RS52481B RS 52481 B RS52481 B RS 52481B YU 86004 A YU86004 A YU 86004A YU P86004 A YUP86004 A YU P86004A RS 52481 B RS52481 B RS 52481B
Authority
RS
Serbia
Prior art keywords
hfa
anhydrate
suspension formulation
tiotropium bromide
crystalline tiotropium
Prior art date
Application number
YU86004A
Other languages
English (en)
Serbian (sr)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Publication of YU86004A publication Critical patent/YU86004A/sh
Publication of RS52481B publication Critical patent/RS52481B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
YU86004A 2002-03-28 2003-03-20 FORMULATION OF HFA-SUSPENSION CONTAINING ANHYDRATE RS52481B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats
PCT/EP2003/002899 WO2003082244A2 (fr) 2002-03-28 2003-03-20 Formulations de suspensions d'un anhydrate contenant un gaz propulseur hfa

Publications (2)

Publication Number Publication Date
YU86004A YU86004A (sh) 2006-08-17
RS52481B true RS52481B (en) 2013-02-28

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
YU86004A RS52481B (en) 2002-03-28 2003-03-20 FORMULATION OF HFA-SUSPENSION CONTAINING ANHYDRATE

Country Status (21)

Country Link
EP (1) EP1492498A2 (fr)
JP (1) JP5147158B2 (fr)
KR (1) KR101005717B1 (fr)
CN (1) CN1642525A (fr)
AU (1) AU2003221509B2 (fr)
BR (1) BR0308709A (fr)
CA (1) CA2479638C (fr)
DE (1) DE10214264A1 (fr)
EA (1) EA008610B1 (fr)
EC (1) ECSP045322A (fr)
HR (1) HRP20040890A2 (fr)
IL (1) IL163696A0 (fr)
ME (1) ME00246B (fr)
MX (1) MXPA04009338A (fr)
NO (1) NO20044004L (fr)
NZ (1) NZ536030A (fr)
PL (1) PL371295A1 (fr)
RS (1) RS52481B (fr)
UA (1) UA79776C2 (fr)
WO (1) WO2003082244A2 (fr)
ZA (1) ZA200405637B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1881980E (pt) * 2005-05-02 2012-12-06 Boehringer Ingelheim Int Novas formas cristalinas de brometo de tiotrópio
CA2606552A1 (fr) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Formes cristallines de bromure de tiotropium
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
TWI792140B (zh) * 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
TR201902687T4 (tr) 2013-03-15 2019-03-21 Pearl Therapeutics Inc İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
EP3515439B1 (fr) * 2016-09-19 2021-12-15 Mexichem Fluor S.A. de C.V. Composition pharmaceutique comprenant du bromure de tiotropium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DK1102579T3 (da) * 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
AU2002214030A1 (en) * 2000-10-31 2002-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses

Also Published As

Publication number Publication date
NO20044004L (no) 2004-10-05
HRP20040890A2 (en) 2005-06-30
NZ536030A (en) 2006-07-28
CA2479638C (fr) 2011-01-04
ME00246B (fr) 2011-05-10
KR20040098022A (ko) 2004-11-18
EP1492498A2 (fr) 2005-01-05
PL371295A1 (en) 2005-06-13
JP5147158B2 (ja) 2013-02-20
ECSP045322A (es) 2005-01-28
CN1642525A (zh) 2005-07-20
CA2479638A1 (fr) 2003-10-09
EA008610B1 (ru) 2007-06-29
KR101005717B1 (ko) 2011-01-05
MEP47308A (en) 2011-02-10
MXPA04009338A (es) 2005-01-25
WO2003082244A3 (fr) 2004-02-05
YU86004A (sh) 2006-08-17
UA79776C2 (en) 2007-07-25
AU2003221509B2 (en) 2008-01-24
EA200401159A1 (ru) 2005-04-28
DE10214264A1 (de) 2003-10-16
WO2003082244A2 (fr) 2003-10-09
JP2005527550A (ja) 2005-09-15
BR0308709A (pt) 2005-01-04
ZA200405637B (en) 2005-07-27
AU2003221509A1 (en) 2003-10-13
IL163696A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
ES2156412T3 (es) Mezclas con 1,1,1,3,3-pentafluorobutano.
HK1079091A1 (en) Hfa-suspension formulations containing an anticholinergic
NO20053163D0 (no) Kjolerkuldemedier.
GB1536813A (en) Propellant compositions for aerosols
ATE164864T1 (de) Flüssiges kohlendioxid enthaltende treibmittel
MY116821A (en) Constant boiling compositions of fluorinated hydrocarbons
FR2361454A1 (fr) Compositions de propulseurs pour aerosols
AR049660A1 (es) Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion
RS52481B (en) FORMULATION OF HFA-SUSPENSION CONTAINING ANHYDRATE
MY124307A (en) Constant boiling compositions of fluorinated hydrocarbons
DE60024311D1 (de) Kühlmittelzusammensetzungen
ES2147168T1 (es) Composicion refrigerante.
KR910021359A (ko) 디메틸에테르 및 1, 1, 1, 2- 테트라플루오로에탄의 혼합물 및 그의 응용
DK1560892T3 (da) Kølemiddelsammensætninger
EP1093889A3 (fr) Gaz propulseur pour outil entraíné par combustion
MX9205538A (es) Composiciones de punto de ebullicion sustancialmente constante de difluorometano y 1,1,1-trifluoroetano o perfluoroetano.
GB941105A (en) Room and air deodorant compositions
EP0626421A4 (fr) Composition d'agent porogene, production de mousse au moyen de ladite composition et mousse ainsi produite.
DE69004344D1 (de) Azeotrope von Wasserstoff enthaltenden Kohlenstoffen mit Butanen.
FR2375313A1 (fr) Melanges a point d'ebullition constant de 1-chloro-2,2,2-trifluoroethane et d'hydrocarbures et halohydrocarbures
KR910000985A (ko) 에어로졸 조성물
JPH0549711A (ja) イオウ系化合物を含む消火剤
JPS6012321B2 (ja) エアゾ−ル殺虫剤
DK0815165T3 (da) Azetrope sammensætninger af perfluorhexan eller 1,1,1,4,4,4-hexafluorbutan eller 1,3-dioxolan og carbonhydrider med 5 eller 6 carbonatomer
AU4413900A (en) Combustible gas mixture and use thereof in gas cutting operations